PRNewswire

New funding will help tackle multidrug-resistant Klebsiella pneumoniae. BANGALORE, India, Dec. 19, 2024 /PRNewswire/ — GangaGen is pleased to announce today that it has secured the third installment of its phased funding grant from CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceuti

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: